New Study Reveals a Hidden Heart Risk in Your Bedtime Routine
A University of Oulu study found that adults with highly irregular bedtimes face twice the risk of major heart events, even when they achieve recommended sleep duration. Researchers monitored 3,231 participants with wearables for a week and followed them for about ten years, tracking heart attacks and strokes. The irregular group’s bedtime varied by an average of 108 minutes, compared with just 33 minutes for the most consistent sleepers. The results suggest bedtime regularity is a missing piece in cardiovascular risk management.
Life Biosciences Secures $80 Million Series D Financing
Life Biosciences announced the close of a fully‑subscribed $80 million Series D financing. The capital will fund operations through the second half of 2027, enabling the company to complete its Phase 1 trial of ER‑100. It also supports further development of the Partial...
Tricuspid Training Series: Transcatheter Tricuspid Valve Interventions
In a TCTMD podcast released on April 8, 2026, interventional cardiologists Rick Nishimura and Paul Sorajja explored transcatheter solutions for severe symptomatic tricuspid regurgitation. The discussion highlighted how catheter‑based repairs and replacements can address patients deemed too high‑risk for conventional surgery. They...
Keratin May Act as a 'Brake' For Skin Inflammation, Pointing to Potential Treatments
Researchers at the University of Michigan discovered that keratin 16, a structural protein in skin, acts as a molecular brake on inflammation. Mutations or loss of the KRT16 gene caused a surge in type I interferon signaling, leading to severe skin inflammation...
AbbVie Files Lawsuit to Address ‘Outdated’ Drug Discount Eligibility Program
AbbVie has filed a lawsuit against the U.S. Health and Human Services Department seeking updated guidance on the 340B drug discount program. The company argues that current rules allow hospitals and clinics to claim discounts for patients with minimal or...
Inside the Challenging Development of a Low-Friction Micropump
Trelleborg Medical Solutions engineered a 15 mm, lubricant‑free micropump for wearable drug delivery, delivering 2‑10 µL per dose. The project required a novel LSR material that bonded to a PBT housing on one side while remaining ultra‑low friction on the other, and...
HRSA Announces $135 Million Funding Boost for Rural Health and Nutrition Services
The Health Resources and Services Administration (HRSA) announced more than $135 million in new funding to boost nutrition services and strengthen the rural health workforce. $125 million will help over 350 health centers expand food‑based interventions aimed at chronic‑disease prevention, while $11.25 million...
Insurer Must Cover Mental Health Facility in Sex Harassment Case: Court
A federal appeals court ruled that Allied World Specialty Insurance must defend American Behavioral Health Systems against sexual‑harassment allegations, rejecting the insurer’s claim that a policy exclusion for sexual abuse barred coverage. The 9th U.S. Circuit held that a complaint can...
Lupin Shares to Be in Focus on Thursday as USFDA Approves Dapagliflozin and Metformin Tablets
Lupin announced U.S. FDA approval of its dapagliflozin and metformin hydrochloride extended‑release tablets, covering four dosage strengths and matching the brand Xigduo XR in efficacy. The approval follows the company’s recent acquisition of European eye‑care specialist VISUfarma, which contributed roughly $58 million...
Unpaid Tourist Medical Bills Push Thailand Toward Mandatory Insurance Rule
Thailand is weighing a rule that would require foreign tourists to carry accident insurance upon entry after public hospitals report growing losses from unpaid treatment costs. The Ministry of Public Health estimates unpaid bills from uninsured visitors exceed 100 million baht...
CorTec Becomes First German BCI Company to Get FDA Breakthrough Designation
The U.S. FDA granted Breakthrough Device designation to CorTec GmbH’s Brain Interchange, a fully implantable brain‑computer interface aimed at stroke rehabilitation. The system combines cortical signal recording with adaptive electrical stimulation in a closed‑loop platform to restore motor function. CorTec...
First Patients Treated in New PFA Trial
Pulse Biosciences has begun treating the first U.S. patients in the NANOPULSE‑AF pivotal trial using its nPulse nanosecond pulsed field ablation system for drug‑resistant paroxysmal atrial fibrillation. The device delivers five‑second, non‑thermal lesions without catheter repositioning, achieving a median 21‑minute...
These AI-Powered Guide Dogs Don't Just Lead, They Talk
Binghamton University researchers have built a robot guide dog that uses GPT‑4 to converse with visually impaired users, offering route planning and real‑time verbal navigation cues. The system was demonstrated at AAAI 2026 and tested with seven legally blind participants who...
States Move to Curb Private Equity in Healthcare as Federal Bill Targets Hospitals and Nursing Homes
State lawmakers are tightening rules on private‑equity ownership of health‑care providers, highlighted by Oregon's SB 951, the nation’s most restrictive law enacted in June 2025. Similar measures are emerging in California, Washington and Pennsylvania, while a federal proposal, the Take Back Our...
Michigan Hospitals Cut Pediatric X-Rays for Respiratory Illnesses by 40%
Michigan hospitals participating in a statewide quality‑improvement collaborative cut chest X‑ray use for pediatric respiratory illnesses by nearly 40 %. The program, launched in 2019 and funded by Blue Cross Blue Shield of Michigan and Blue Care Network, analyzed 114,238 emergency‑department...
ED Strategy Redesign Aims to Improve Dementia Patient Outcomes
Memorial Sloan Kettering researchers have devised an emergency department (ED) redesign aimed at improving outcomes for patients with dementia. The intervention combines targeted problem‑identification tools, psychosocial considerations for patient‑caregiver‑clinician triads, and structured post‑discharge follow‑up. A concise, one‑hour training curriculum equips...
Subcutaneous Tepezza Demonstrates Phase III Efficacy in Thyroid Eye Disease
Amgen reported that its subcutaneous formulation of teprotumumab‑trbw (Tepezza) met the primary endpoint in a phase III trial for moderate‑to‑severe active thyroid eye disease, with 76.7% of patients achieving a ≥2 mm proptosis reduction versus 19.6% on placebo. The study also showed...
Artificial Intelligence and Biology: AI’s Potential for Launching a Novel Era for Health and Medicine
Artificial intelligence is reshaping biology by rapidly predicting protein structures and gene variant effects, exemplified by AlphaFold’s Nobel‑winning breakthrough and AlphaGenome’s genome‑wide insights. Researchers are moving beyond correlation‑based models toward hybrid frameworks that combine causal knowledge with multimodal datasets, as...
Acting Attorney General Forms National Fraud Enforcement Division
Acting U.S. Attorney General Todd Blanche announced the creation of the National Fraud Enforcement Division (NFED) to combat fraud in taxpayer‑funded programs, a move spurred by rising Medicaid fraud concerns in Minnesota. The division consolidates oversight of existing fraud units,...
Umary and Related Products
The U.S. Food and Drug Administration has issued a warning that Umary and Amazy dietary supplements contain undeclared prescription‑drug ingredients, including dexamethasone, diclofenac, and omeprazole. Laboratory testing confirmed these hidden drugs, prompting voluntary nationwide recalls by several distributors. Parallel alerts...
Philips Warns Not to Use Certain Nebulizers in Trilogy Evo Ventilator Recall
Philips has issued a field‑safety notice prohibiting the use of non‑pneumatic nebulizers, such as vibrating‑mesh models, with its Trilogy Evo line of ventilators. The FDA logged the action as a Class I recall, affecting more than 113,700 devices worldwide, including the Evo,...
Just How Bad Are Generative AI Chatbots for Our Mental Health?
Generative AI chatbots now serve over 987 million users worldwide, with roughly 64 % of American teens engaging them for advice, emotional support, and companionship. A recent analysis of 71 news stories covering 36 mental‑health crises found media coverage heavily weighted toward...
High-Dose Wegovy Debuts at $399 for Self-Paying Patients
Novo Nordisk has launched Wegovy HD, a 7.2‑mg semaglutide injection, priced at $399 per month for self‑paying patients. The FDA approved the higher‑dose formulation in March, expanding the company’s weight‑loss portfolio beyond the previous 2.4‑mg limit. The new price is...
13 Health Systems Seeking Revenue Cycle Vice Presidents
Thirteen hospitals and health systems have posted senior‑level openings for revenue cycle leadership. The positions, ranging from vice president of revenue cycle management to associate vice president of revenue cycle systems, are located across a broad geographic spread including Missouri,...
PhRMA Head Steve Ubl to Step Down at End of Year
Steve Ubl, who has led the pharmaceutical lobbying coalition PhRMA for more than a decade, announced he will step down at the end of the year. Under his stewardship, the group amplified its influence on Capitol Hill, championing policies that...
11 Hospitals, Health Systems Adding New C-Suite Roles in 2026
In 2024, eleven hospitals and health systems announced inaugural C‑suite roles slated to begin in 2026, covering positions such as chief clinical officer, chief health AI transformation officer, chief nursing executive, and chief digital and information officer. The appointments span...
How Can More Efficient Data Sharing Improve Patient Care Plans?
Health Information Exchanges (HIEs) let clinicians, pharmacists and patients securely share vital medical data electronically, boosting care speed, safety and cost efficiency. Yet each HIE often uses its own data format, leading to fragmented records when patients see multiple providers....
Forecasting Protein Aggregation with an Improved Algorithm
Scientists at the Autonomous University of Barcelona have released the fourth generation of their protein‑aggregation forecasting algorithm, which leverages AlphaFold structural data and molecular‑dynamics simulations. The tool lets users evaluate aggregation risk, explore mutations, scan protein families, and assess pH...
Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest
The Trump administration revived pharmaceutical tariffs, imposing a 100% base duty on imported patented drugs and their active ingredients. While generic medicines and UK imports are exempt, firms with Most Favored Nation (MFN) agreements—such as Pfizer and Eli Lilly—are shielded, and...
Insurer Must Defend Doctor Accused of ‘Fertility Fraud’
A Connecticut appellate court reversed a lower‑court decision, requiring medical‑malpractice insurer Integris Insurance to cover the defense costs of Dr. Narendra Tohan, accused of using his own sperm in IVF procedures without patient consent. The court found the insurer had...
FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing Opioid Pain Relievers or Medicines to Treat Opioid...
The FDA has mandated that manufacturers add naloxone guidance to the prescribing information for all opioid pain relievers and medications for opioid use disorder (OUD). Health‑care professionals must now discuss naloxone availability with every patient receiving an opioid prescription or...
Some Epic Health Systems Now Connect to SSA Through TEFCA
Epic Systems announced that health organizations using its EHR can now exchange patient records with the Social Security Administration instantly through the Trusted Exchange Framework and Common Agreement (TEFCA). The move adds five health systems—AltaMed, Citizen Potawatomi Nation Health Services,...
Bayesian Statistical Analysis (BSA) Demonstration Project
The FDA’s CDER Center for Clinical Trial Innovation (C3TI) has launched a Bayesian Statistical Analysis (BSA) demonstration project to encourage the use of Bayesian methods in simple phase 3 trials. The program lets sponsors collaborate with FDA statisticians to apply Bayesian...
UNC Health, UNC-Chapel Hill Debut Platform for AI Development
UNC-Chapel Hill and UNC Health have launched SHIRE, a secure cloud‑based platform that lets credentialed researchers access curated electronic health record data for AI development. The system, built by the NC TraCS Informatics team, offers scalable computing power while maintaining...
FDA Warns About Risks of Dental Problems Associated with Buprenorphine Medicines Dissolved in the Mouth to Treat Opioid Use Disorder...
The FDA has issued a new safety warning that buprenorphine tablets and films dissolved under the tongue or against the cheek can cause dental problems such as cavities, abscesses, and even tooth loss. The alert applies to both single‑ingredient buprenorphine...
Imaging Delays Surge as Radiology Workforce Hits Limits: Study
Imaging interpretation turnaround times for Medicare fee‑for‑service patients have more than doubled between 2014 and 2023, rising from roughly 2.2 hours to 4.6 hours on average. The slowdown is especially acute for advanced modalities, with CT scans experiencing a 318%...
FDA Issues Series of Guidances Under Drug Competition Action Plan
The FDA released three new guidances under its Drug Competition Action Plan to streamline generic drug reviews. A final guidance clarifies the use of Information Requests and Discipline Review Letters, a revised draft updates procedures for aligning ANDA labeling with...
Approved First Generic for Apokyn Injection Cartridges Requires Separately Packaged Pen
The FDA approved Sage Chemical’s generic apomorphine hydrochloride cartridges, the first generic version of Apokyn for treating "off" episodes in advanced Parkinson’s disease. The generic cartridges work only with the proprietary Apokyn Pen, which must be obtained separately through specialty...
FDA Announces Evusheld Is Not Currently Authorized for Emergency Use in the U.S.
The FDA revised Evusheld's Emergency Use Authorization on Jan. 26, 2023, limiting its use to situations where susceptible SARS‑CoV‑2 variants comprise 90% or less of national cases. With current CDC data showing over 90% of circulating variants are resistant, Evusheld...
FDA Updates Sotrovimab Emergency Use Authorization
The U.S. Food and Drug Administration revoked the Emergency Use Authorization for sotrovimab on April 5, 2022, after CDC data showed the Omicron BA.2 sub‑variant accounted for more than 50 % of cases in every HHS region. Earlier in the year the agency...
Advancing Novel Surrogate Endpoints For Rare Disease Drug Development Workshop - 05/18/2026
The FDA is hosting a virtual workshop on May 18, 2026 to advance novel surrogate endpoints for rare disease drug development. The event is part of the Rare Disease Endpoint Advancement (RDEA) Pilot Program, mandated by PDUFA VII and FDORA, which requires up...
FDA Works to Protect Consumers From Potentially Harmful OTC Skin Lightening Products
The U.S. Food and Drug Administration issued warning letters to twelve companies for selling over‑the‑counter skin‑lightening products that contain hydroquinone, an ingredient not approved for OTC use. The agency highlighted serious adverse events such as rashes, facial swelling, and permanent...
New Nasal Flu Vaccine Shows Promise in Mice
Researchers at Georgia State University have engineered an intranasal influenza vaccine that uses cell‑derived extracellular vesicles (EVs) to display inverted hemagglutinin (HA) proteins. The upside‑down HA exposes the conserved stalk region while masking the variable head, prompting cross‑protective immunity. In...
HeyDonto AI Technology Closes $20M Seed Round at $200M Valuation to Scale Conduit — The Dental Interoperability Exchange
HeyDonto AI Technology announced a $20 million seed round that values the company at $200 million. The capital will be used to scale Conduit, its AI‑powered dental interoperability platform that links dental practice systems with medical EHRs, payers and patient apps. Conduit...
Patients Are Using Chatbots to Fight Medical Bills, With Mixed Results
Patients are increasingly turning to free AI chatbots like Claude and ChatGPT to dispute medical bills, exemplified by a couple who used Claude to challenge a $22,604 emergency‑room charge. The American Hospital Association has flagged this growing DIY trend as...
Merck Adjusts Its Vaccine Supply Deal in China; Soleno Withdraws EU Application
Merck and its Chinese partner Zhifei have revised their COVID‑19 vaccine supply agreement, lowering the committed volume and adding a flexible delivery schedule to reflect waning demand. The updated contract preserves Zhifei’s exclusive distribution rights but shifts risk back to...
Jeito Capital, Prominent Biotech Investor, Raises $1.2B for Next Fund
Jeito Capital announced the close of its Jeito II fund, raising €1 billion (about $1.2 billion) – the largest capital raise ever for an independent European biopharma fund. The fund will back 15‑20 clinical‑stage drugmakers, allocating up to €150 million ($162 million) per company across...
Skilled Nursing Facilities Get a Proposed 2.4% Increase
The Centers for Medicare & Medicaid Services (CMS) has proposed a 2.4% increase to the Skilled Nursing Facility Prospective Payment System for fiscal year 2027, derived from a 3.2% market basket adjustment offset by a 0.8% productivity factor. Facilities that...
Rune Labs Launches StrivePD Guardian, an AI Companion for Parkinson’s Disease Powered by Claude
Rune Labs has introduced StrivePD Guardian, an AI‑powered companion for Parkinson’s disease that operates as an agentic system. The app, built on Anthropic’s Claude model, routes patient queries to specialized sub‑agents such as a Medication Assistant and PD Coach, while...
Gilead Takes Another Big Swing at Expanding Beyond HIV
Gilead Sciences has earmarked roughly $11 billion this year for three strategic acquisitions aimed at strengthening its cancer and immunology pipelines. The moves signal a decisive pivot away from its historic reliance on HIV therapeutics toward broader biotech markets. The targeted...